EULAR Network of Trial centres (ENTRI)

The  EULAR Network of Trial centres (ENTRI)   is an initiative by the EULAR Research Centre, dedicated to facilitating rheumatic and musculoskeletal diseases (RMDs)-related clinical trial delivery for patient benefit, across all countries represented within the  EULAR membership .      

For more information, please contact: 

ENTRI aims to:    

1. Create a network of experienced clinical trials centres with access to large cohorts of patients with RMDs, accessible to all investigators and sponsors from both public and private sectors.    

2. Build capacity and training in clinical trials and experimental medicine studies in close collaboration with EULAR’s Impact of RMDs Survey, RheumaFacts,  Advanced Tissue Analysis and the EULAR School of Rheumatology.

3.Provide RMD-related clinical trials toolkits underpinned by best practice.

For more information, please contact: .  

See infographic

Benefits of membership of ENTRI  

  • Opportunities to participate in clinical research 

  • Opportunities to collaborate on research studies with other ENTRI members 

  • Participating in industry sponsored research studies and clinical trials 

  • Contribute to developing the ENTRI clinical trials toolkit 

  • Providing mentorship 

  • Training opportunities for aspiring young investigators 



Meet the EULAR Clinical Research Sub-Committee Chair, Andrew Cope.

Related Information
Sign Up to the EULAR Research Newsletter

To keep up to date with EULAR and developments around the EULAR Research Centre, sign up to receive the Newsletter here.

Related News Stories

The EULAR Research Consultation Service

How does it work and what can you get?

​​​See infographic

EULAR Research Interview Series


Contact the Research team at